Evidence map›Paper›PMID 20005134›Full record

ArticleImmunity2009

T cell receptor CDR3 sequence but not recognition characteristics distinguish autoreactive effector and Foxp3(+) regulatory T cells.

Xin Liu, Phuong Nguyen, Wei Liu, Cheng Cheng, Meredith Steeves, John C Obenauer, Jing Ma, Terrence L Geiger

Open access · bronzeAbstract read
In one paragraph

Article in Immunity, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 65 citations in OpenAlex.

  1. Article
  2. Regulatory T Cells: the Many Faces of Foxp3.Journal of clinical immunology · 2019
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. FOXP3+ regulatory T cells and their functional regulation.Cellular & molecular immunology · 2015
    Review
  12. Article
  13. Once a Treg, always a Treg?Immunological reviews · 2014
    Review
  14. Article
  15. Article
  16. CTLA-4 controls the thymic development of both conventional and regulatory T cells through modulation of the TCR repertoire.Proceedings of the National Academy of Sciences of the United States of America · 2013
    Article
  17. Article
  18. Treg cells, life history, and diversity.Cold Spring Harbor perspectives in biology · 2012
    Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Xin LiuDepartment of Pathology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
Phuong Nguyen
Wei Liu
Cheng Cheng
Meredith Steeves
John C Obenauer
Jing Ma
Terrence L Geiger
St. Jude Children's Research Hospital · US

Funding

TREATMENT OF AUTOIMMUNITY WITH REGULATORY T LYMPHOCYTESR01AI056153 · NIAID · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI GEIGER, TERRENCE L · 2004 to 2013
$3.9M
NIAID NIH HHS R01 AI056153
6 · The paper itself

Abstract

The source, specificity, and plasticity of the forkhead box transcription factor 3 (Foxp3)(+) regulatory T (Treg) and conventional T (Tconv) cell populations active at sites of autoimmune pathology are not well characterized. To evaluate this, we combined global repertoire analyses and functional assessments of isolated T cell receptors (TCR) from TCRalpha retrogenic mice with autoimmune encephalomyelitis. Treg and Tconv cell TCR repertoires were distinct, and autoantigen-specific Treg and Tconv cells were enriched in diseased tissue. Autoantigen sensitivity and fine specificity of these cells intersected, implying that differences in responsiveness were not responsible for lineage specification. Notably, autoreactive Treg and Tconv cells could be fully distinguished by an acidic versus aliphatic variation at a single TCR CDR3 residue. Our results imply that ontogenically distinct Treg and Tconv cell repertoires with convergent specificities for autoantigen respond during autoimmunity and argue against more than limited plasticity between Treg and Tconv cells during autoimmune inflammation.

Indexed as

AnimalsAutoantigensCD4-Positive T-LymphocytesEncephalomyelitis, Autoimmune, ExperimentalForkhead Transcription FactorsGlycoproteinsInterleukin-2MiceMice, Inbred C57BLMice, KnockoutMyelin-Oligodendrocyte GlycoproteinPeptide FragmentsReceptors, Antigen, T-Cell, alpha-betaT-Lymphocytes, RegulatoryAutoantigensForkhead Transcription FactorsFoxp3 protein, mouseGlycoproteinsInterleukin-2Myelin-Oligodendrocyte Glycoproteinmyelin oligodendrocyte glycoprotein (35-55)Peptide FragmentsReceptors, Antigen, T-Cell, alpha-betaT-cell receptor Vbeta 8.2

Identifiers

PMID20005134
PMCPMC2878844
OpenAlexW2034001655

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.